hovon/llpc transplant brave: novel salvage chemotherapy for r/r hodgkin lymphoma
Published 3 years ago • 84 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
5:56
once a non-verbal child with autism, ava hopes her story will help other kids with special needs
-
10:55
what is low-grade non-hodgkin lymphoma?
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
2:46
update of the admiral trial: gilteritinib vs salvage chemotherapy prior to hsct in flt-3 mutated aml
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:40
exploring the genomic landscape of hodgkin lymphoma with whole-genome sequencing
-
1:55
novel biological therapies for managing non-hodgkin lymphoma
-
2:52
the promise of adcs in the future treatment of hl
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
0:42
haploidentical transplant in argentina
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
2:19
novel treatment options for non-hodgkin lymphoma